↓ Skip to main content

Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature

Overview of attention for article published in World Journal of Surgical Oncology, November 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Afatinib combined with anlotinib in the treatment of lung adenocarcinoma patient with novel HER2 mutation: a case report and review of the literature
Published in
World Journal of Surgical Oncology, November 2021
DOI 10.1186/s12957-021-02444-7
Pubmed ID
Authors

Huanhuan Xu, Qi Liang, Xian Xu, Shanyue Tan, Sumeng Wang, Yiqian Liu, Lingxiang Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 17%
Student > Ph. D. Student 1 17%
Student > Bachelor 1 17%
Researcher 1 17%
Student > Master 1 17%
Other 0 0%
Unknown 1 17%
Readers by discipline Count As %
Unspecified 1 17%
Sports and Recreations 1 17%
Immunology and Microbiology 1 17%
Social Sciences 1 17%
Medicine and Dentistry 1 17%
Other 0 0%
Unknown 1 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 December 2021.
All research outputs
#13,410,980
of 22,759,618 outputs
Outputs from World Journal of Surgical Oncology
#359
of 2,042 outputs
Outputs of similar age
#210,356
of 500,357 outputs
Outputs of similar age from World Journal of Surgical Oncology
#6
of 42 outputs
Altmetric has tracked 22,759,618 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,042 research outputs from this source. They receive a mean Attention Score of 2.0. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 500,357 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.